O'Leary Brendan
Insider CIK 1500269 · TSRX Director · PRTO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PRTO PROTEON THERAPEUTICS INC | A Award deriv | 2016-06-09 | 2016-06-14 | 6,666 | — | $0 | 6,666 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | A Award deriv | 2015-06-02 | 2015-06-03 | 6,666 | — | $0 | 6,666 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 2,341,664 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 2,478,183 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 2,336,956 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 5,000,000 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | D To issuer deriv | 2014-10-27 | 2014-10-29 | 1,965,454 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 4,000,070 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion | 2014-10-27 | 2014-10-29 | 123,846 | — | $0 | 1,304,028 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy | 2014-10-27 | 2014-10-29 | 83,170 | $10.00 | $831.7K | 1,387,198 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion | 2014-10-27 | 2014-10-29 | 374,921 | — | $0 | 374,921 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion | 2014-10-27 | 2014-10-29 | 180,014 | — | $0 | 554,935 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion | 2014-10-27 | 2014-10-29 | 181,125 | — | $0 | 736,060 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion | 2014-10-27 | 2014-10-29 | 252,052 | — | $0 | 1,180,182 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion | 2014-10-27 | 2014-10-29 | 192,070 | — | $0 | 928,130 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 15,000 | $5.73 | $86.0K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 12,000 | $9.50 | $114.0K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 12,000 | $5.24 | $62.9K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 12,000 | $8.45 | $101.4K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer | 2013-09-11 | 2013-09-13 | 21,302 | — | $0 | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | A Award deriv | 2013-05-21 | 2013-05-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TSRX Trius Therapeutics Inc | A Award deriv | 2012-05-22 | 2012-05-24 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TSRX Trius Therapeutics Inc | M Exercise deriv | 2012-03-26 | 2012-03-28 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TSRX Trius Therapeutics Inc | M Exercise deriv | 2012-03-26 | 2012-03-28 | 9,302 | — | $0 | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | M Exercise | 2012-03-26 | 2012-03-28 | 9,302 | $1.29 | $12.0K | 9,302 | SEC↗ |
| TSRX Trius Therapeutics Inc | M Exercise | 2012-03-26 | 2012-03-28 | 12,000 | $4.00 | $48.0K | 21,302 | SEC↗ |